SCHEMBL20209355

SCHEMBL20209355

c1ccc2c(c1)ccc1oc3cc4oc5ccc6ccccc6c5c4cc3c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.49
PAX8 Q06710 2/20 0.49
ABCG2 Q9UNQ0 2/20 0.49
CYP1A1 P04798 1/20 0.49
CYP1A2 P05177 1/20 0.49
FYN P06241 1/20 0.49
MAPK3 P27361 1/20 0.49
TDP1 Q9NUW8 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
PRKDC P78527 2/20 0.45
HSD17B10 Q99714 3/20 0.44
TSHR P16473 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP2A6 P11509 1/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
MEN1 O00255 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29705977 1.00 AHR (0.49) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL16807708 0.94 AHR (0.50) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL24583338 0.93 KDM4E (0.50) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL5470714 0.90 AHR (0.47) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL19082488 0.87 KDM4E (0.42) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL22680516 0.87 AHR (0.40) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL31010718 0.87 AHR (0.40) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL29705929 0.87 HPRT1 (0.46) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL17228828 0.86 KDM4E (0.52) AHRPAX8ABCG2CYP1A1CYP1A2
SCHEMBL13085117 0.86 ALDH1A1 (0.59) AHRPAX8ABCG2CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204521-A1 ELECTROACTIVE COMPOUNDS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2022-06-30 US disclosed
US-11239426-B2 Electroactive compounds LG CHEM, LTD. 2022-02-01 US disclosed
WO-2020231669-A1 ELECTROACTIVE COMPOUNDS DUPONT ELECTRONICS, INC. (US) 2020-11-19 WO disclosed
WO-2018097937-A1 ELECTROACTIVE COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11239426-B2 Electroactive compounds KCNN2, HCN2, KCNN3 AHR 1187/4885PAX8 1129/4885ABCG2 902/4885
US-20220204521-A1 ELECTROACTIVE COMPOUNDS AHR, CYP1B1, KCNH1 AHR 1/4885PAX8 1711/4885ABCG2 1012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.